All New issues

Desjardins Maximum Return Japanese Equity Principal Protected Notes, Series 29

Additional Informations

Issuer:	Fédération des caisses Desjardins
Securities Offered:	Desjardins Maximum Return Japanese Equity Principal Protected Notes, Series 29
Issue Price:	$ 100 per note
Minimum:	$ 1,000 (10 notes)
Reference Index:	The reference basket is an equally weighted portfolio of common shares issued by 20 companies. Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Nippon Yusen KK, Sekisui House Limited, Inpex Corporation, Sumitomo Mitsui Trust Group Inc., Japan Post Bank Co., Ltd., SoftBank Corporation, Canon Inc., FUJIFILM Holdings Corporation, Bridgestone Corporation, Mitsui & Company Limited, Mitsubishi Corporation, Toyota Motor Corporation, Sumitomo Corporation, ITOCHU Corporation, ORIX Corporation, KDDI Corporation, Mitsubishi UFJ Financial Group, Inc., Asahi Group Holdings Ltd.
Settlement date:	Transaction date plus 2 days. **All purchases are closed without the possibility of cancellation ** Please refer to Information Statement Document, Right of cancellation.
Issuance Date:	November 20, 2026
Maturity Date:	November 20, 2031
RRSP & TFSA Eligibility:	Yes
Term:	5 years
Participation Rate:	Participation rate of 170.00%
Maximum Return:	Maximum return of 39.95 %
Principal Protected:	The capital is 100% guaranteed at maturity
Early Trading Charge:	This fee goes from 3.25 %, initially to 0% after 300 days.
Secondary Market:	DSN01563
Commission received from the Issuer:	Desjardins online brokerage will receive from the issuer a remuneration of $2.50 for each note sold (equivalent to 2.50 % of the principal amount)
Subscription close:	November 13, 2026, noon. Books can close without any further notice.
Offering Document:	For more detailed information please refer to the prospectus.
Investment highlights:	To view the Investment highlights please refer to this document.

The content of this page is transmitted strictly for informational purposes. Investments must be selected in accordance with the investor's respective objectives. Desjardins Online Brokerage does not issue any recommendations or endorsements concerning any particular product, its potential value or appropriateness, or any specific strategy. It is highly recommended to read the prospectus before making any type of investment.